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1. Introduction 
 
Cyclic depsipeptides are a class of biologically active secondary metabolites, which contain not 
only amide bonds as part of their ring structure, but also other bonds, usually lactone bonds. Their 
biological activity is diverse, being based mainly on their capability to transport selectively metal 
ions through cell membranes, and they are sought after as potential anticancer, antiviral, 
antibiotic and anti-inflammatory drugs [1]. 
One of the many methods known for their synthesis is the direct amide cyclization [2]: a 
suspension of an amide of type A in toluene is treated with dry HCl gas. Cyclization by 
elimination of the corresponding ammonium chloride leads to the intermediate 1,3-oxazol-5(4H)-
one of type B. In the absence of other nucleophiles, B undergoes a ring enlargement via 
intramolecular nucleophilic attack of the hydroxy group at the carbonyl C-atom of the 
neighboring lactone group, to give the cyclodepsipeptide C  (Scheme 1). 
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Scheme 1 
 
This method has been used successfully for the synthesis of 6-, 9-, 12- and 15-membered [3] and 
larger ring systems [4]. For example, α-hydroxy acid derivatives of type 1 (n = 1) under the 
‘direct amide cyclization’ conditions led to morpholinediones of type 3 [5] (Scheme 2). Recently, 
we have shown that diamides of type A, which contain  β-hydroxy acids, i.e. 1 (n = 2), under 
these reaction conditions did not give the expected 7-membered cyclodepsipeptides, and only 
their dimers, the 14-membered rings 4 were isolated in good yields [6][7] (Scheme 2). Treatment 
of γ-hydroxy acid derivatives (1, n = 3) with HCl gas in toluene yielded no cyclodepsipeptides at 
all. Instead, the only products isolated were the hydrochlorides of imino lactones 5, which are 
unstable in solution and isomerize in polar solvents or on silicagel to give the chlorinated acids 6 
[8] (Scheme 2). 
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 Scheme 2 
 
In all cases so far, the formation of the intermediate oxazolone 2 was proven chemically or by IR 
spectroscopy. The results show that there is a relationship between the number of C-atoms 
between the OH and CONH groups and the type of product formed. Therefore, it was of interest 
to subject δ-hydroxy acid amides 1 (n = 4) to the conditions of the ‘direct amide cyclization’, 
which could yield either a 9- or 18-membered cyclodepsipeptide on the one hand, or a 6-
membered imino lactone on the other. The result of a first example is shown below. 
 
2. Results and Discussion 
 
Since the previously used standard methods for syntheses of β- and γ-hydroxy acids [8] were not 
applicable to their δ-hydroxy analogues, we used the method of Goto et al. [9]: 3,3-dimethyl-γ-
butyrolactone 7 was treated with NaOH and Ac2O, which led to the O-protected 5-acetoxy-3,3-
dimethylpentanoic acid (8) in moderate yield (Scheme 3). 
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Scheme 3 
 
The reaction of the acid 8 with 2,2,N-trimethyl-N-phenyl-2H-azirin-3-amine (9) [10] yielded the 
protected diamide 10. After deprotection  with LiOH, 11 was subjected to the ‘direct amide 
cyclization’ (DAC) conditions (HCl gas, toluene, 100o). Trituration of the crude product with 
CH2Cl2, a procedure that has allowed the isolation of the imino lactone hydrochlorides 5 without 
isomerization to the corresponding chlorinated acids [8], yielded in the present case the chloro 
acid 12 directly as the only product in good yield. Recrystallization from MeCN gave crystals 
which were suitable for an X-ray crystal structure determination (Fig. 1). 
 
Fig. 1. ORTEP Plot [11] of the molecular structure of 12 (arbitrary numbering of the atoms; 50% 
probability ellipsoids) 
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Although the compound is achiral, it has crystallized in a polar space group and the absolute 
structure has been determined unambiguously. The OH group forms an intermolecular H-bond 
with the amide O-atom of a neighboring molecule, thereby linking the molecules into extended 
chains, which run parallel to the [0 1 0] direction and can be described by a graph set motif [12] 
of C(7). The amide group forms an intermolecular H-bond with the carboxylate carbonyl O-atom 
of a different neighboring molecule. This interaction links the molecules into extended chains, 
which run parallel to the [1 0 0] direction and can be descdibed by a graph set motif of C(5). The 
combination of both interactions generates a two-dimensional framework that lies parallel to the 
(0 0 1) plane (Fig. 2). 
 
Fig. 2. Molecular packing of 12, showing the H-bonding interactions 
 
In our earlier studies, the ring size has a controlling influence over which of the possible products 
is formed from compounds of type 1 under the DAC conditions. With β-hydroxy acids (n = 2, 
Scheme 2) 14-membered rings 4 (cyclodimers) are preferred over 7-membered ones, while the 
formation of 5-membered imino lactones 5 is preferred over the corresponding 8-membered 
cyclodepsipeptides in the case of γ-hydroxy acids (n = 3). Therefore, the expected product in the 
case where 1 contains a δ-hydroxy acid was either a 6-membered imino lactone analogous to 5, or 
a 9-membered cyclodepsipeptide. As the 9-membered cyclodepsipeptide 13 has already been 
synthesized via DAC from the linear precursor  14 [3][13] (Scheme 4), the formation of 12 was a 
surprise. 
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Scheme 4 
 
The formation of 12 proceeds most probably through the intermediate 1,3-oxazolone derivative 
16 and the 6-membered imino lactone 17, which apparently is unstable under these conditions 
and, by analogy with 5, isomerizes spontaneously to give the chloro acid 12. 
 
3. Conclusions 
 
The DAC conditions were applied to the linear precursor 11, which contains a δ-hydroxy acid. 
Surprisingly, no cyclic depsipeptide was formed under these conditions. Thus, the dependence of 
the result of the DAC reaction on whether an α-, β-, γ-, or δ-hydroxy acid diamide is used has 
been confirmed. The general use of the ‘direct amide cyclization’ for the synthesis of cyclic 
depsipeptides is apparently limited to linear precursors which contain α-hydroxy acid amides. 
The use of β-hydroxy acid precursors is also possible for the formation of larger rings [4], but can 
lead to cyclodimers or side products as well. 
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Experimental Part 
 
1. General. See [8]. 
 
2. Starting materials. 2,2,N-Trimethyl-N-phenyl-2H-azirin-3-amine (9) was prepared according 
to standard procedures (cf. [8] and refs. cited therein). Butyrolactone 7 was prepared by a known 
method [14]. 
 
3. 5-Acetoxy-3,3-dimethylpentanoic acid (8). To a soln. of 7 (20 mmol, 2560 mg) in MeOH (10 
ml) was added 2N NaOH (11 ml) at 0o. The mixture was stirred at r.t. for 2 h, the solvent 
evaporated i.v. and the remaining H2O was distilled azeotropically with benzene (3 x 10 ml). The 
white residue was dried overnight under h.v.  and then Ac2O (10 ml) was added. After 14 h at 80o, 
the mixture was cooled, the solvent evaporated and the oily residue extracted with AcOEt (5 x 30 
ml). Drying (MgSO4) and CC on SiO2 with CH2Cl2/MeOH 20:1 yielded 1201 mg (32%) of 9. 
Recovered starting material: 980 mg (37%).  IR: 3288s (br), 2971s, 1738vs, 1711vs, 1471w, 
1378s, 1356m, 1244s, 1094s, 1040s, 925w. 1H-NMR: 0.97 (s, Me2C); 1.59-1.71 (m, CH2); 1.99 
(s, MeCO); 2.21 (s, CH2); 4.01 (br. s, CH2O); 10.41 (br. s, COOH). 13C-NMR: 20.7 (q, MeCO); 
27.2 (q, Me2C);  32.0 (s, Me2C), 37.6, 43.9 (2t, 2 CH2); 66.6 (t, CH2O); 171.1 (s, C=O); 177.3 (s, 
COOH). ESI-MS: 211 (100, [M + Na]+). 
 
4. 4-[1-Methyl-1-(N-methyl-N-phenylcarbamoyl)ethylcarbamoyl)-3,3-dimethylbutyl Acetate (10). 
To a soln. of  8 (376 mg,  2 mmol) in dry THF (20 ml), 9 (365 mg, 2.1 mmol) was added. The 
mixture was stirred at r.t. overnight and the solvent evaporated i.v.  CC with CH2Cl2/MeOH 40:1 
yielded 622 mg (86%) of 10. White powder. M.p. 98.1-99.4o. 1H-NMR: 0.97, 1.41 (2s, 2 Me2C); 
1.62 (t, J = 7.1, CH2 ); 1.99 (s, MeCO); 2.08 (s, CH2); 3.19 (s, MeN); 3.1 (t, J = 7.1, CH2O); 6.55 
(s, NH); 7.20-7.39 (m, 5 arom. H). 13C-NMR: 20.8 (q, MeCO); 26.3, 27.0 (2q, 2 Me2C); 33.0 (s, 
Me2C); 41.3 (t, CH2); 42.3 (q, MeN); 48.2 (t, CH2); 58.1 (s, Me2C); 68.7 (t, CH2O); 127.8, 128.0, 
129.3 (3d, 5 arom. CH); 144.6 (s, arom. C); 169.8, 171.6, 173.2 (3s, 3 C=O). ESI-MS: 385 (100, 
[M + Na]+]). 
 
5. 5-Hydroxy-3,3-dimethyl-N-[1-methyl-1-(N-methyl-N-phenylcarbamoyl)ethyl]-pentanamide 
(11). A soln. of 9 (362 mg, 1 mmol) in THF/H2O 2:1 (20 ml) was treated with 4 equiv. of LiOH 
at r.t. for 4 h. Evaporation of the solvent i.v., extraction of the residue with CH2Cl2, drying 
(MgSO4), evaporation i.v. and washing with Et2O yielded the hydroxydiamide 11, which was 
used without further purification. Yield:  298 mg (93%) of 11. White solid. M.p. 128.4-126.0o. 
1H-NMR: 0.99, 1.46 (2s, 2 Me2C); 1.60 (t, J = 7.1, CH2); 2.00 (s, CH2); 3.17 (s, MeN); 3.18 (t, J 
= 7.1, CH2O); 6.51 (s, NH); 7.18-7.36 (m, 5 arom. H). 13C-NMR: 26.4, 28.8 (2q, 2 Me2C); 32.8 
(s, Me2C); 41.4 (t, CH2); 42.4 (q, MeN); 48.2 (t, CH2); 58.2 (s, Me2C); 69.7 (t, CH2O); 127.8, 
128.0, 129.3 (3d, 5 arom. CH); 144.5 (s, arom. C); 171.7, 173.3 (2s, 2 C=O). ESI-MS: 343 (100, 
[M + Na]+). 
 
6. 2-(5-Chloro-3,3-dimethylpentanoylamino)-2-methylpropanoic Acid (12). A suspension of 11 
(80 mg, 0.25 mmol) in dry toluene (30 ml) was heated to 100o and HCl gas was bubbled through 
the suspension for 4-6 min. Then, the mixture was allowed to cool to r.t. while bubbling N2 
through it (ca. 20 min). The solvent was evaporated, the white residue was washed with CH2Cl2 
(3 x 15 ml) and dried in h.v. Yield: 36 mg (59%) of 12. M.p. 118.9-121.0o. IR: 3320vs, 2980s, 
1722vs, 1620s, 1561s, 1466s, 1428s, 1389m, 1246m, 1232m, 1166s, 1092m, 1051w, 945w. 1H-
NMR ((D6)DMSO): 0.97, 1.33 (2s, 2 Me2C); 1.68-1.79 (m, CH2); 1.97 (s, CH2); 3.60-3.69 (m, 
CH2Cl); 7.82 (br. s, NH); 11.81 (br. s, COOH). 13C-NMR ((D6)DMSO): 24.8, 27.2 (q, Me2C); 
33.4, 42.5 (t, CH2); 54.6 (t, CH2Cl); 55.7 (s, Me2C); 169.9, 175.4 (2s, 2 C=O). ESI-MS: 274 (25, 
[M(37Cl) + Na]+), 272 (100, [M(35Cl) + Na]+), 214 (10, [M - Cl]+). 
 
7. X-Ray Crystal-Structure Determination of 12 (Table and Figs. 1,2).3) All measurements were 
made on a Nonius KappaCCD area-detector diffractometer [15] using graphite-monochromated 
MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. The data 
collection and refinement parameters are given in the Table and views of the molecules are 
shown in Figs. 1 and 2. Data reduction was performed with HKL Denzo and Scalepack [16]. The 
                                                  
3) CCDC- 286116 contains supplementary crystallographic data for this paper. These data can be 
obtained free of charge form the Cambridge Crystallographic Data Centre, via 
http://www.ccdc.cam.ac.uk/data_request/cif 
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intensities were corrected for Lorentz and polarization effects, and an absorption correction based 
on the multi-scan method [17] was applied.  Equivalent reflections, other than Friedel pairs, were 
merged. The structure was solved by direct methods using SIR92 [18], which revealed the 
positions of all non-H-atoms.  The non-H-atoms were refined anisotropically.  The hydroxy and 
amide H-atoms were placed in the positions indicated by a difference electron density map and 
their positions were allowed to refine together with individual isotropic displacement parameters.  
All remaining H-atoms were placed in geometrically calculated positions and refined using a 
riding model where each H-atom was assigned a fixed isotropic displacement parameter with a 
value equal to 1.2Ueq of its parent C-atom (1.5Ueq for the methyl groups).  Refinement of the 
structure was carried out on F2 using full-matrix least-squares procedures, which minimised the 
function Σw(Fo2 – Fc2)2.  A correction for secondary extinction was applied. Refinement of the 
absolute structure parameter [19][20] yielded a value of 0.01(6), which confirms that the refined 
model represents the true absolute structure. Neutral atom scattering factors for non-H atoms 
were taken form [21] and the scattering factors for H-atoms were taken from [22]. Anomalous 
dispersion effects were included in Fc [23]; the values for f' and f'' were those of [24]. The values 
of the mass attenuation coefficients are those of [25]. All calculations were performed using for 
the SHELXL97 program [26]. 
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 Table. Crystallographic Data of 12 
 12 
  
Crystallized from CH3CN 
Empirical formula C11H20ClNO3 
Formula weight [g mol-1] 249.74 
Crystal color, habit colorless, plate 
Crystal dimensions [mm] 0.02 × 0.20 × 0.25 
Temp. [K] 160(1) 
Crystal system monoclinic 
Space group P21   
Z 2 
Reflections for cell determination 45269 
2θ range for cell determination [°] 4 – 55 
Unit cell parameters  a [Å] 
                                  b [Å] 
                                  c [Å] 
                                  β [°] 
                                 V [Å3] 
6.1314(3) 
10.4871(5) 
10.4750(5) 
104.760(2) 
651.32(5) 
Dx [g cm-3] 1.273 
µ(MoKα) [mm-1] 0.286 
Scan type φ and ω 
2θ (max) [°] 55 
Transmission factors (min; max) 0.864; 0.996 
Total reflections measured 13304 
Symmetry independent reflections 2950 
Reflections with I > 2σ (I) 2548 
Reflections used in refinement 2950 
Parameters refined; restraints 159; 1 
R [on F; I > 2σ(I) reflections] 0.0372 
wR [on F2; all indept. reflections] 0.0814 
Weighting parameters [a; b]a) 0.0314; 0.1588 
Goodness of fit 1.044 
Secondary extinction coefficient 0.035(5) 
Final ∆ max /σ 0.001 
∆ρ (max; min) [e Å-3] 0.19; -0.16 
 
a) w–1 = σ2(Fo2) + (aP)2 + bP] where P = (Fo2 + 2Fc2)/3 
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